MYC Induces Oncogenic Stress through RNA Decay and Ribonucleotide Catabolism in Breast Cancer.
Saved in:
| Title: | MYC Induces Oncogenic Stress through RNA Decay and Ribonucleotide Catabolism in Breast Cancer. |
|---|---|
| Authors: | Meena JK; Therapeutic Innovation Center (THINC), Baylor College of Medicine, Houston, Texas.; Verna & Marrs McLean Department of Biochemistry and Molecular Pharmacology, Baylor College of Medicine, Houston, Texas., Wang JH; Verna & Marrs McLean Department of Biochemistry and Molecular Pharmacology, Baylor College of Medicine, Houston, Texas.; Medical Scientist Training Program, Baylor College of Medicine, Houston, Texas., Neill NJ; Therapeutic Innovation Center (THINC), Baylor College of Medicine, Houston, Texas.; Verna & Marrs McLean Department of Biochemistry and Molecular Pharmacology, Baylor College of Medicine, Houston, Texas.; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas., Keough D; The School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Australia., Putluri N; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas., Katsonis P; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas., Koire AM; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas., Lee H; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Bowling EA; Therapeutic Innovation Center (THINC), Baylor College of Medicine, Houston, Texas.; Verna & Marrs McLean Department of Biochemistry and Molecular Pharmacology, Baylor College of Medicine, Houston, Texas., Tyagi S; Verna & Marrs McLean Department of Biochemistry and Molecular Pharmacology, Baylor College of Medicine, Houston, Texas., Orellana M; Verna & Marrs McLean Department of Biochemistry and Molecular Pharmacology, Baylor College of Medicine, Houston, Texas., Dominguez-Vidaña R; Verna & Marrs McLean Department of Biochemistry and Molecular Pharmacology, Baylor College of Medicine, Houston, Texas., Li H; Verna & Marrs McLean Department of Biochemistry and Molecular Pharmacology, Baylor College of Medicine, Houston, Texas., Eagle K; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas., Danan C; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas., Chung HC; Verna & Marrs McLean Department of Biochemistry and Molecular Pharmacology, Baylor College of Medicine, Houston, Texas., Yang AD; Therapeutic Innovation Center (THINC), Baylor College of Medicine, Houston, Texas.; Verna & Marrs McLean Department of Biochemistry and Molecular Pharmacology, Baylor College of Medicine, Houston, Texas.; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas.; Medical Scientist Training Program, Baylor College of Medicine, Houston, Texas., Wu W; Verna & Marrs McLean Department of Biochemistry and Molecular Pharmacology, Baylor College of Medicine, Houston, Texas.; Medical Scientist Training Program, Baylor College of Medicine, Houston, Texas., Kurley SJ; Verna & Marrs McLean Department of Biochemistry and Molecular Pharmacology, Baylor College of Medicine, Houston, Texas., Ho BM; Verna & Marrs McLean Department of Biochemistry and Molecular Pharmacology, Baylor College of Medicine, Houston, Texas.; Medical Scientist Training Program, Baylor College of Medicine, Houston, Texas., Zoeller JR; Therapeutic Innovation Center (THINC), Baylor College of Medicine, Houston, Texas.; Verna & Marrs McLean Department of Biochemistry and Molecular Pharmacology, Baylor College of Medicine, Houston, Texas.; Medical Scientist Training Program, Baylor College of Medicine, Houston, Texas., Olson CM; Therapeutic Innovation Center (THINC), Baylor College of Medicine, Houston, Texas.; Verna & Marrs McLean Department of Biochemistry and Molecular Pharmacology, Baylor College of Medicine, Houston, Texas., Meerbrey KL; Therapeutic Innovation Center (THINC), Baylor College of Medicine, Houston, Texas.; Verna & Marrs McLean Department of Biochemistry and Molecular Pharmacology, Baylor College of Medicine, Houston, Texas., Lichtarge O; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas., Sreekumar A; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas., Dacso CC; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas., Guddat LW; The School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Australia., Rejman D; Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czech Republic., Hocková D; Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czech Republic., Janeba Z; Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czech Republic., Simon LM; Therapeutic Innovation Center (THINC), Baylor College of Medicine, Houston, Texas., Lin CY; Therapeutic Innovation Center (THINC), Baylor College of Medicine, Houston, Texas.; Verna & Marrs McLean Department of Biochemistry and Molecular Pharmacology, Baylor College of Medicine, Houston, Texas.; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas.; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas., Pillon MC; Therapeutic Innovation Center (THINC), Baylor College of Medicine, Houston, Texas.; Verna & Marrs McLean Department of Biochemistry and Molecular Pharmacology, Baylor College of Medicine, Houston, Texas., Westbrook TF; Therapeutic Innovation Center (THINC), Baylor College of Medicine, Houston, Texas.; Verna & Marrs McLean Department of Biochemistry and Molecular Pharmacology, Baylor College of Medicine, Houston, Texas.; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas.; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas. |
| Source: | Cancer discovery [Cancer Discov] 2024 Sep 04; Vol. 14 (9), pp. 1699-1716. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
